Related Experiment Video
Updated: Sep 23, 2026

Targeted Plasma Membrane Delivery of a Hydrophobic Cargo Encapsulated in a Liquid Crystal Nanoparticle Carrier
Published on: February 8, 2017
pH-Responsive drug delivery system for tumor therapy
Bowen Wei1,2, Jiadong Li1,2, Yani Cui3
1National Engineering Research Center for Biomaterials, Sichuan University, 29# Wangjiang Road, Chengdu, Sichuan, 610064, P. R. China. zhaomingda0107@163.com.
Abstract:
Cancer, as a leading cause of mortality globally, poses significant treatment challenges, including inadequate tumor targeting, severe systemic toxicity, and multidrug resistance. The advent of nanomedicine delivery systems (NDDS) in recent years has led to novel approaches for enhancing drug targeting and mitigating adverse reactions. Among them, pH-responsive NDDS exploit pH gradients in the tumor microenvironment to enable programmed drug release and improved tumor accumulation, thereby enhancing therapeutic efficacy. This article systematically reviews the design strategies, working mechanisms, and application prospects of pH-responsive NDDS in cancer therapy. Firstly, based on the chemical structure of materials, the design of pH-responsive materials through protonation mechanisms and acid-sensitive chemical bonds is introduced. Second, we focus on reviewing how pH responsiveness enhanced the physicochemical properties and biological regulation functions of different categories of NDDS. Then, an overview of the multi-responsive NDDS based on pH response, with a particular emphasis on the significance of pH-responsive design. Finally, we summarize the advantages and limitations of pH-responsive NDDS and offer insights into the future development of pH-responsive materials in the context of evolving nanomaterial science.
Related Concept Videos
Modified-Release Drug Delivery Systems: Site-Targeted
Drug Delivery Systems: Different Types
Modified-Release Drug Delivery Systems: Classification
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Modified-Release Drug Delivery Systems: Rate-Programmed II
Oral Drug Delivery Systems: Continuous-Release Systems